- Report
- May 2025
- 383 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 116 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 393 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 375 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 287 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 278 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 73 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 483 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 478 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 207 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 371 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 271 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 204 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 282 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 371 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 374 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 88 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 480 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 290 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 297 Pages
Global
From €5338EUR$5,850USD£4,536GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more
